These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23599030)

  • 1. A method to adjust for stage coding changes in the National Program of Cancer Registries illustrated for colorectal cancer.
    Austin H; Duong LM; King J; Richardson LC; Eheman C
    J Registry Manag; 2012; 39(2):62-8. PubMed ID: 23599030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and colorectal cancer recurrence and progression captured by five U.S. population-based registries: Findings from National Program of Cancer Registries patient-centered outcome research.
    Thompson TD; Pollack LA; Johnson CJ; Wu XC; Rees JR; Hsieh MC; Rycroft R; Culp M; Wilson R; Wu M; Zhang K; Benard V
    Cancer Epidemiol; 2020 Feb; 64():101653. PubMed ID: 31918179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007.
    Wilson RJ; Ryerson AB; Zhang K; Dong X
    J Registry Manag; 2014; 41(2):72-6. PubMed ID: 25153012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
    Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
    J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.
    Lawrance S; Bui C; Mahindra V; Arcorace M; Cooke-Yarborough C
    BMC Cancer; 2019 Aug; 19(1):850. PubMed ID: 31462255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited colorectal cancer registries in the United States.
    Church J; Kiringoda R; LaGuardia L
    Dis Colon Rectum; 2004 May; 47(5):674-8. PubMed ID: 15037932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the staging schema on melanoma cancer reporting, 1999 to 2006.
    Lai SM; King JB; Garimella S; Keighley J; Lewis M
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S95-103. PubMed ID: 22018073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005.
    Cheng L; Eng C; Nieman LZ; Kapadia AS; Du XL
    Am J Clin Oncol; 2011 Dec; 34(6):573-80. PubMed ID: 21217399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?
    Keating J; Pater P; Lolohea S; Wickremesekera K
    N Z Med J; 2003 May; 116(1174):U437. PubMed ID: 12766783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
    Weir HK; Thun MJ; Hankey BF; Ries LA; Howe HL; Wingo PA; Jemal A; Ward E; Anderson RN; Edwards BK
    J Natl Cancer Inst; 2003 Sep; 95(17):1276-99. PubMed ID: 12953083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study.
    McDavid K; Schymura MJ; Armstrong L; Santilli L; Schmidt B; Byers T; Steele CB; O'Connor L; Schlag NC; Roshala W; Darcy D; Matanoski G; Shen T; Bolick-Aldrich S;
    Cancer Causes Control; 2004 Dec; 15(10):1057-66. PubMed ID: 15801489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.
    Innos K; Reima H; Baburin A; Paapsi K; Aareleid T; Soplepmann J
    Cancer Epidemiol; 2018 Feb; 52():112-119. PubMed ID: 29294434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modernizing an Online Data Monitoring System for the CDC's National Program of Cancer Registries.
    Zhang K; Bhavsar S; Ren Y; Stanger J; Guo J; Wilson R; Wu M; O'Neil ME
    J Registry Manag; 2020; 47(3):172-174. PubMed ID: 34128924
    [No Abstract]   [Full Text] [Related]  

  • 14. Declining Proportion of Incident Squamous Cell Carcinomas of the Oral Cavity Coded as Unknown for American Joint Committee TNM Stage:SEER Registries, 2004-2014.
    Polednak AP
    J Registry Manag; 2018; 45(3):104-108. PubMed ID: 31017879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choropleth map design for cancer incidence, part 1.
    Richards TB; Berkowitz Z; Thomas CC; Foster SL; Gardner A; King JB; Ledford K; Royalty J
    Prev Chronic Dis; 2010 Jan; 7(1):A23. PubMed ID: 20040238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries.
    Kweon SS; Kim MG; Kang MR; Shin MH; Choi JS
    J Epidemiol; 2017 Jul; 27(7):299-304. PubMed ID: 28279589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choropleth map design for cancer incidence, part 2.
    Richards TB; Berkowitz Z; Thomas CC; Foster SL; Gardner A; King JB; Ledford K; Royalty J
    Prev Chronic Dis; 2010 Jan; 7(1):A24. PubMed ID: 20040239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality rates by stage-at-diagnosis.
    Clinton K
    Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of Year 2 Data Quality Evaluation of CDC's National Program of Cancer Registries: Weighing the Evidence, Identifying Research Gaps, and Evaluating Outputs of a Prevention Research Agenda.
    Traverso-Ortiz M; Duran D; Mesnard M; Ng D; Dailey S
    J Registry Manag; 2022; 49(2):75-78. PubMed ID: 37261193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.